You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CAMBIA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CAMBIA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00276419 ↗ Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin Terminated Mayo Clinic Phase 2/Phase 3 2005-06-01 The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
NCT02287376 ↗ Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds Completed Depomed Phase 4 2015-01-01 Study Objectives: 1. The primary objective is to characterize the pharmacokinetics of a single oral administration of 50 mg Cambia in pediatric subjects, ages 12-17 years with a diagnosis of episodic migraine with or without aura. 2. The secondary objectives are to determine: 1. The safety and tolerability of Cambia from a single dose 2. Three-month safety evaluation of Cambia in outpatient usage in this population
NCT02664116 ↗ IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine Unknown status Depomed Phase 4 2016-01-01 This research will be conducted to see if the oral drug Cambia is as effective in relieving severe migraine headaches as the injectable drug ketorolac.
NCT02664116 ↗ IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine Unknown status Scripps Health Phase 4 2016-01-01 This research will be conducted to see if the oral drug Cambia is as effective in relieving severe migraine headaches as the injectable drug ketorolac.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CAMBIA

Condition Name

Condition Name for CAMBIA
Intervention Trials
Breast Pain 1
Migraine 1
Migraine Headache 1
Non-cyclical Mastalgia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CAMBIA
Intervention Trials
Migraine Disorders 2
Headache 1
Mastodynia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CAMBIA

Trials by Country

Trials by Country for CAMBIA
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CAMBIA
Location Trials
California 1
New York 1
Florida 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CAMBIA

Clinical Trial Phase

Clinical Trial Phase for CAMBIA
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CAMBIA
Clinical Trial Phase Trials
Terminated 1
Unknown status 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CAMBIA

Sponsor Name

Sponsor Name for CAMBIA
Sponsor Trials
Depomed 2
Mayo Clinic 1
Scripps Health 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CAMBIA
Sponsor Trials
Other 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.